- Investing Ideas
- Spanish Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Spanish Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
3
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
3 companies
Grifols
Market Cap: €5.5b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
GRF
€9.13
7D
1.6%
1Y
-25.3%
Faes Farma
Market Cap: €1.4b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.39
7D
-3.1%
1Y
-3.8%
Pangaea Oncology
Market Cap: €53.9m
A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.50
7D
-0.7%
1Y
-11.8%